vs

Side-by-side financial comparison of Apyx Medical Corp (APYX) and CuriosityStream Inc. (CURI). Click either name above to swap in a different company.

CuriosityStream Inc. is the larger business by last-quarter revenue ($19.2M vs $19.2M, roughly 1.0× Apyx Medical Corp). Apyx Medical Corp runs the higher net margin — -6.8% vs -19.7%, a 12.9% gap on every dollar of revenue. On growth, CuriosityStream Inc. posted the faster year-over-year revenue change (35.8% vs 34.7%). CuriosityStream Inc. produced more free cash flow last quarter ($3.9M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 26.5%).

Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

APYX vs CURI — Head-to-Head

Bigger by revenue
CURI
CURI
1.0× larger
CURI
$19.2M
$19.2M
APYX
Growing faster (revenue YoY)
CURI
CURI
+1.1% gap
CURI
35.8%
34.7%
APYX
Higher net margin
APYX
APYX
12.9% more per $
APYX
-6.8%
-19.7%
CURI
More free cash flow
CURI
CURI
$6.7M more FCF
CURI
$3.9M
$-2.8M
APYX
Faster 2-yr revenue CAGR
APYX
APYX
Annualised
APYX
36.8%
26.5%
CURI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
APYX
APYX
CURI
CURI
Revenue
$19.2M
$19.2M
Net Profit
$-1.3M
$-3.8M
Gross Margin
62.6%
Operating Margin
0.1%
-17.6%
Net Margin
-6.8%
-19.7%
Revenue YoY
34.7%
35.8%
Net Profit YoY
71.9%
-34.6%
EPS (diluted)
$-0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APYX
APYX
CURI
CURI
Q4 25
$19.2M
$19.2M
Q3 25
$12.9M
$18.4M
Q2 25
$11.4M
$19.0M
Q1 25
$9.4M
$15.1M
Q4 24
$14.2M
$14.1M
Q3 24
$11.5M
$12.6M
Q2 24
$12.1M
$12.4M
Q1 24
$10.2M
$12.0M
Net Profit
APYX
APYX
CURI
CURI
Q4 25
$-1.3M
$-3.8M
Q3 25
$-2.0M
$-3.7M
Q2 25
$-3.8M
$784.0K
Q1 25
$-4.2M
$319.0K
Q4 24
$-4.6M
$-2.8M
Q3 24
$-4.7M
$-3.1M
Q2 24
$-6.6M
$-2.0M
Q1 24
$-7.6M
$-5.0M
Gross Margin
APYX
APYX
CURI
CURI
Q4 25
62.6%
Q3 25
64.4%
Q2 25
62.3%
Q1 25
60.1%
Q4 24
63.0%
Q3 24
60.5%
Q2 24
61.7%
Q1 24
58.1%
Operating Margin
APYX
APYX
CURI
CURI
Q4 25
0.1%
-17.6%
Q3 25
-6.5%
-24.5%
Q2 25
-22.6%
2.5%
Q1 25
-32.4%
0.5%
Q4 24
-21.4%
-27.4%
Q3 24
-31.6%
-25.8%
Q2 24
-45.7%
-20.6%
Q1 24
-64.6%
-30.4%
Net Margin
APYX
APYX
CURI
CURI
Q4 25
-6.8%
-19.7%
Q3 25
-15.4%
-20.4%
Q2 25
-33.2%
4.1%
Q1 25
-44.0%
2.1%
Q4 24
-32.5%
-19.9%
Q3 24
-40.9%
-24.3%
Q2 24
-54.0%
-16.4%
Q1 24
-74.0%
-42.0%
EPS (diluted)
APYX
APYX
CURI
CURI
Q4 25
$-0.07
Q3 25
$-0.06
Q2 25
$0.01
Q1 25
$0.01
Q4 24
$-0.05
Q3 24
$-0.06
Q2 24
$-0.19
$-0.04
Q1 24
$-0.22
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APYX
APYX
CURI
CURI
Cash + ST InvestmentsLiquidity on hand
$31.7M
$27.3M
Total DebtLower is stronger
$37.5M
Stockholders' EquityBook value
$14.5M
$41.5M
Total Assets
$66.8M
$75.7M
Debt / EquityLower = less leverage
2.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APYX
APYX
CURI
CURI
Q4 25
$31.7M
$27.3M
Q3 25
$25.1M
$27.8M
Q2 25
$29.3M
$28.1M
Q1 25
$31.0M
$33.4M
Q4 24
$31.7M
$32.1M
Q3 24
$28.0M
$33.2M
Q2 24
$32.7M
$39.5M
Q1 24
$37.3M
$38.8M
Total Debt
APYX
APYX
CURI
CURI
Q4 25
$37.5M
Q3 25
$37.5M
Q2 25
$37.5M
Q1 25
$37.5M
Q4 24
$37.5M
Q3 24
$37.5M
Q2 24
Q1 24
Stockholders' Equity
APYX
APYX
CURI
CURI
Q4 25
$14.5M
$41.5M
Q3 25
$5.8M
$47.2M
Q2 25
$7.3M
$49.8M
Q1 25
$10.5M
$58.1M
Q4 24
$14.2M
$57.8M
Q3 24
$11.0M
$62.2M
Q2 24
$14.7M
$64.8M
Q1 24
$20.3M
$67.0M
Total Assets
APYX
APYX
CURI
CURI
Q4 25
$66.8M
$75.7M
Q3 25
$57.4M
$74.7M
Q2 25
$58.2M
$78.7M
Q1 25
$60.2M
$85.3M
Q4 24
$64.8M
$86.2M
Q3 24
$60.7M
$87.6M
Q2 24
$65.4M
$90.9M
Q1 24
$70.7M
$94.6M
Debt / Equity
APYX
APYX
CURI
CURI
Q4 25
2.58×
Q3 25
6.41×
Q2 25
5.17×
Q1 25
3.57×
Q4 24
2.64×
Q3 24
3.40×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APYX
APYX
CURI
CURI
Operating Cash FlowLast quarter
$-2.5M
$4.0M
Free Cash FlowOCF − Capex
$-2.8M
$3.9M
FCF MarginFCF / Revenue
-14.6%
20.5%
Capex IntensityCapex / Revenue
1.4%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APYX
APYX
CURI
CURI
Q4 25
$-2.5M
$4.0M
Q3 25
$-3.5M
$4.4M
Q2 25
$-1.2M
$2.8M
Q1 25
$-702.0K
$1.9M
Q4 24
$-2.9M
$3.0M
Q3 24
$-4.4M
$2.3M
Q2 24
$-4.3M
$2.2M
Q1 24
$-6.3M
$666.0K
Free Cash Flow
APYX
APYX
CURI
CURI
Q4 25
$-2.8M
$3.9M
Q3 25
$-4.1M
Q2 25
$-1.5M
Q1 25
$-757.0K
$1.8M
Q4 24
$-3.2M
Q3 24
$-4.6M
Q2 24
$-4.6M
Q1 24
$-6.4M
FCF Margin
APYX
APYX
CURI
CURI
Q4 25
-14.6%
20.5%
Q3 25
-31.5%
Q2 25
-13.2%
Q1 25
-8.0%
12.2%
Q4 24
-22.4%
Q3 24
-40.0%
Q2 24
-38.0%
Q1 24
-62.2%
Capex Intensity
APYX
APYX
CURI
CURI
Q4 25
1.4%
0.1%
Q3 25
4.0%
0.0%
Q2 25
2.3%
0.0%
Q1 25
0.6%
0.5%
Q4 24
1.7%
0.0%
Q3 24
1.3%
0.0%
Q2 24
2.4%
0.0%
Q1 24
0.3%
0.0%
Cash Conversion
APYX
APYX
CURI
CURI
Q4 25
Q3 25
Q2 25
3.56×
Q1 25
6.03×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons